Management of acute pulmonary embolism during COVID-19 pandemic

In late December 2019, COVID-19 was first reported from China, leading to a serious pandemic, and changed the agenda of the world for months. Although data are accumulating from many countries everyday, it is known that the most common reason for hospitalization of COVID-19 patients is severe respiratory distress. Acute pulmonary embolism is an important cause of death in hospitalized patients. Rapid diagnosis and treatment have a vital importance, as the majority of deaths occur with shock within the first few hours after presentation. In this article, we present a summary of COVID-19 pandemic and give an expert opinion report for common problems related to pulmonary thromboembolic disease and treatment modalities during the outbreak.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 2020:e200994.
2. Clayton TC, Gaskin M, Meade TW. Recent respiratory infection and risk of venous thromboembolism: casecontrol study through a general practice database. Int J Epidemiol 2011;40:819-27.
3. Chong PY, Chui P, Ling AE, Franks TJ, Tai DY, Leo YS, et al. Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis. Arch Pathol Lab Med 2004;128:195-204.
4. Mei H, Hu Y. [Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19]. Zhonghua Xue Ye Xue Za Zhi 2020;41:185-91.
5. Arpaia GG, Caleffi A, Marano G, Laregina M, Erba G, Orlandini F, et al. Padua prediction score and IMPROVE score do predict in-hospital mortality in Internal Medicine patients. Intern Emerg Med 2020. [Online ahead of print]
6. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 2010;8:2450-7.
7. Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK, et al. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest 2011;139:69-79.
8. Xu J, Wang L, Zhao L, Li F, Liu J, Zhang L, et al. Risk assessment of venous thromboembolism and bleeding in COVID-19 patients. Respiratory Research 2020.
9. Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C, et al. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med 2018;378:1965-75.
10. Dresden S, Mitchell P, Rahimi L, Leo M, Rubin-Smith J, Bibi S, et al. Right ventricular dilatation on bedside echocardiography performed by emergency physicians aids in the diagnosis of pulmonary embolism. Ann Emerg Med 2014;63:16-24.
11. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020;41:543-603.
12. Meyer G, Vieillard-Baron A, Planquette B. Recent advances in the management of pulmonary embolism: focus on the critically ill patients. Ann Intensive Care 2016;6:19.
13. Stein PD, Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med 2012;125:465-70.
14. Wang C, Zhai Z, Yang Y, Wu Q , Cheng Z, Liang L, et al. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial. Chest 2010;137:254-62.
15. Kuo WT, Sista AK, Faintuch S, Dariushnia SR, Baerlocher MO, Lookstein RA, et al. Society of Interventional Radiology Position Statement on Catheter-Directed Therapy for Acute Pulmonary Embolism. J Vasc Interv Radiol 2018;29:293-7.
16. Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M; “MOPETT” Investigators. Moderate pulmonary embolism treated with thrombolysis (from the "MOPETT" Trial). Am J Cardiol 2013;111:273-7.
17. Dentali F, Ageno W, Becattini C, Galli L, Gianni M, Riva N, et al. Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis. Thromb Res 2010;125:518-22.
18. Raslan IA, Chong J, Gallix B, Lee TC, McDonald EG. Rates of Overtreatment and Treatment-Related Adverse Effects Among Patients With Subsegmental Pulmonary Embolism. JAMA Intern Med 2018;178:1272-4.
19. Bariteau A, Stewart LK, Emmett TW, Kline JA. Systematic Review and Meta-analysis of Outcomes of Patients With Subsegmental Pulmonary Embolism With and Without Anticoagulation Treatment. Acad Emerg Med 2018;25:828-35.
20. Sharafuddin MJ, Hicks ME. Current status of percutaneous mechanical thrombectomy. Part I. General principles. J Vasc Interv Radiol 1997;8:911-21.
21. Chechi T, Vecchio S, Spaziani G, Giuliani G, Giannotti F, Arcangeli C, et al. Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolism. Catheter Cardiovasc Interv 2009;73:506-13.
22. Bonvini RF, Roffi M, Bounameaux H, Noble S, Müller H, Keller PF, et al. AngioJet rheolytic thrombectomy in patients presenting with high-risk pulmonary embolism and cardiogenic shock: a feasibility pilot study. EuroIntervention 2013;8:1419-27.
23. Wunderlich N, Franke J, Sievert H. A novel technique to remove a right atrial thrombotic mass attached to a patent foramen ovale (PFO) closure device. Catheter Cardiovasc Interv 2013. [Online ahead of print]
24. Kucher N, Boekstegers P, Müller OJ, Kupatt C, BeyerWestendorf J, Heitzer T, et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014;129:479-86.
25. Piazza G, Hohlfelder B, Jaff MR, Ouriel K, Engelhardt TC, Sterling KM, et al. A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, CatheterDirected, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. JACC Cardiovasc Interv 2015;8:1382-92.
26. Kuo WT, Banerjee A, Kim PS, DeMarco FJ Jr, Levy JR, Facchini FR, et al. Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT): Initial Results From a Prospective Multicenter Registry. Chest 2015;148:667-73.
27. Bloomer TL, El-Hayek GE, McDaniel MC, Sandvall BC, Liberman HA, Devireddy CM, et al. Safety of catheter-directed thrombolysis for massive and submassive pulmonary embolism: Results of a multicenter registry and meta-analysis. Catheter Cardiovasc Interv 2017;89:754-60.
28. Dumantepe M, Uyar I, Teymen B, Ugur O, Enc Y. Improvements in pulmonary artery pressure and right ventricular function after ultrasound-accelerated catheterdirected thrombolysis for the treatment of pulmonary embolism. J Card Surg 2014;29:455-63.
29. Ozcinar E, Cakici M, Dikmen Yaman N, Baran C, Aliyev A, Inan B, et al. Thrombus resolution and right ventricular functional recovery using ultrasound-accelerated thrombolysis in acute massive and submassive pulmonary embolism. Int Angiol 2017;36:428-37.
30. Kaymaz C, Akbal OY, Hakgor A, Tokgoz HC, Karagoz A, Tanboga IH, et al. A five-year, single-centre experience on ultrasound-assisted, catheter-directed thrombolysis in patients with pulmonary embolism at high risk and intermediate to high risk. EuroIntervention 2018;14:1136-43.
31. Keeling WB, Sundt T, Leacche M, Okita Y, Binongo J, Lasajanak Y, et al. Outcomes After Surgical Pulmonary Embolectomy for Acute Pulmonary Embolus: A MultiInstitutional Study. Ann Thorac Surg 2016;102:1498-502.
32. Akay TH, Sezgin A, Ozkan S, Gultekin B, Aslim E, Aslamaci S. Successful surgical treatment of massive pulmonary embolism after coronary bypass surgery. Tex Heart Inst J 2006;33:498-500.
33. Azari A, Beheshti AT, Moravvej Z, Bigdelu L, Salehi M. Surgical embolectomy versus thrombolytic therapy in the management of acute massive pulmonary embolism: Short and long-term prognosis. Heart Lung 2015;44:335-9.
34. Aymard T, Kadner A, Widmer A, Basciani R, Tevaearai H, Weber A, et al. Massive pulmonary embolism: surgical embolectomy versus thrombolytic therapy--should surgical indications be revisited? Eur J Cardiothorac Surg 2013;43:90-4.
35. Mudy K, DiBardino DJ, Askew JA, Sun BK. Surgical pulmonary embolectomy for massive and submassive pulmonary embolism. Journal of the Minneapolis Heart Institute Foundation: Spring/Summer 2018;2:44-50.
36. Neely RC, Byrne JG, Gosev I, Cohn LH, Javed Q , Rawn JD, et al. Surgical Embolectomy for Acute Massive and Submassive Pulmonary Embolism in a Series of 115 Patients. Ann Thorac Surg 2015;100:1245-51;.
37. Darling E, Searles B, Nasrallah F, Robins M, You X, Gatto L, et al. High-volume, zero balanced ultrafiltration improves pulmonary function in a model of post-pump syndrome. J Extra Corpor Technol 2002;34:254-9.
38. Carney DE, Lutz CJ, Picone AL, Gatto LA, Ramamurthy NS, Golub LM, et al. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation 1999;100:400-6.
39. Rubens FD, Mesana T. The inflammatory response to cardiopulmonary bypass: a therapeutic overview. Perfusion 2004;19:S5-12.
40. Bikdeli B, Chatterjee S, Desai NR, Kirtane AJ, Desai MM, Bracken MB, et al. Inferior vena cava filters to prevent pulmonary embolism: systematic review and metaanalysis. J Am Coll Cardiol 2017;70:1587-97.
41. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016;149:315-52.
42. Goldhaber SZ. Pulmonary embolism. In: Mann D, Zipes D, Libby P, Bonow R, editors. Braunwald’s heart disease: a textbook of cardiovascular medicine. 10th ed. Philadelphia: Saunders; 2015. p. 1664-81
43. Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020;46:854-87.
44. Bhorade S, Christenson J, O'connor M, Lavoie A, Pohlman A, Hall JB. Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med 1999;159:571-9.
45. Chen L, Liu P, Gao H, Sun B, Chao D, Wang F, et al. Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing. Clin Infect Dis 2004;39:1531-5.
46. Jardin F, Genevray B, Brun-Ney D, Margairaz A. Dobutamine: a hemodynamic evaluation in pulmonary embolism shock. Crit Care Med 1985;13:1009-12.
47. JCS Joint Working Group. Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009). Circ J 2011;75:1258-81.
48. Corsi F, Lebreton G, Bréchot N, Hekimian G, Nieszkowska A, Trouillet JL, et al. Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation. Crit Care 2017;21:76.
49. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol 2020. [Online ahead of print]
50. T.C. Sağlık Bakanlığı, Bilim Kurulu. COVID-19 (SARSCoV-2 Enfeksiyonu) Rehberi; 2020.
51. Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 2018;39:1330-93.
52. Bikdeli B, Jimenez D, Hawkins M, Ortíz S, Prandoni P, Brenner B, et al. Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE). Thromb Haemost 2018;118:214-24.
53. Xie Y, Xie Y, Wang X, Yang P, Zhang S. COVID19 Complicated by acute pulmonary embolism. Radiol Cardiothorac Imaging 2020;2:e200067.
54. Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Heart J 2020;41:1858.
55. Chen J, Wang X, Zhang S, Liu B, Wu X, Wang Y, et al. Findings of acute pulmonary embolism in COVID-19 patients. Lancet Infect Dis 2020. [In Press].
56. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62.
57. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020;18:1094-9.
58. Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M, et al. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost 2019;17:1989-94.

APA	Aliyev A, Dumantepe M, Şırlak M, Doganci S, POLAT A, aydin u, BEYAZPINAR D, Oğuz E, erdil n, Kaymaz C, Akay H (2021). Management of acute pulmonary embolism during COVID-19 pandemic. , 77 - 90. 10.9739/tjvs.2021.807
Chicago	Aliyev Anar,Dumantepe Mert,Şırlak Mustafa,Doganci Suat,POLAT ADIL,aydin unal,BEYAZPINAR Deniz Sarp,Oğuz Emrah,erdil nevzat,Kaymaz Cihangir,Akay Hakkı Tankut Management of acute pulmonary embolism during COVID-19 pandemic. (2021): 77 - 90. 10.9739/tjvs.2021.807
MLA	Aliyev Anar,Dumantepe Mert,Şırlak Mustafa,Doganci Suat,POLAT ADIL,aydin unal,BEYAZPINAR Deniz Sarp,Oğuz Emrah,erdil nevzat,Kaymaz Cihangir,Akay Hakkı Tankut Management of acute pulmonary embolism during COVID-19 pandemic. , 2021, ss.77 - 90. 10.9739/tjvs.2021.807
AMA	Aliyev A,Dumantepe M,Şırlak M,Doganci S,POLAT A,aydin u,BEYAZPINAR D,Oğuz E,erdil n,Kaymaz C,Akay H Management of acute pulmonary embolism during COVID-19 pandemic. . 2021; 77 - 90. 10.9739/tjvs.2021.807
Vancouver	Aliyev A,Dumantepe M,Şırlak M,Doganci S,POLAT A,aydin u,BEYAZPINAR D,Oğuz E,erdil n,Kaymaz C,Akay H Management of acute pulmonary embolism during COVID-19 pandemic. . 2021; 77 - 90. 10.9739/tjvs.2021.807
IEEE	Aliyev A,Dumantepe M,Şırlak M,Doganci S,POLAT A,aydin u,BEYAZPINAR D,Oğuz E,erdil n,Kaymaz C,Akay H "Management of acute pulmonary embolism during COVID-19 pandemic." , ss.77 - 90, 2021. 10.9739/tjvs.2021.807
ISNAD	Aliyev, Anar vd. "Management of acute pulmonary embolism during COVID-19 pandemic". (2021), 77-90. https://doi.org/10.9739/tjvs.2021.807

APA	Aliyev A, Dumantepe M, Şırlak M, Doganci S, POLAT A, aydin u, BEYAZPINAR D, Oğuz E, erdil n, Kaymaz C, Akay H (2021). Management of acute pulmonary embolism during COVID-19 pandemic. Turkish journal of vascular surgery, 30(1), 77 - 90. 10.9739/tjvs.2021.807
Chicago	Aliyev Anar,Dumantepe Mert,Şırlak Mustafa,Doganci Suat,POLAT ADIL,aydin unal,BEYAZPINAR Deniz Sarp,Oğuz Emrah,erdil nevzat,Kaymaz Cihangir,Akay Hakkı Tankut Management of acute pulmonary embolism during COVID-19 pandemic. Turkish journal of vascular surgery 30, no.1 (2021): 77 - 90. 10.9739/tjvs.2021.807
MLA	Aliyev Anar,Dumantepe Mert,Şırlak Mustafa,Doganci Suat,POLAT ADIL,aydin unal,BEYAZPINAR Deniz Sarp,Oğuz Emrah,erdil nevzat,Kaymaz Cihangir,Akay Hakkı Tankut Management of acute pulmonary embolism during COVID-19 pandemic. Turkish journal of vascular surgery, vol.30, no.1, 2021, ss.77 - 90. 10.9739/tjvs.2021.807
AMA	Aliyev A,Dumantepe M,Şırlak M,Doganci S,POLAT A,aydin u,BEYAZPINAR D,Oğuz E,erdil n,Kaymaz C,Akay H Management of acute pulmonary embolism during COVID-19 pandemic. Turkish journal of vascular surgery. 2021; 30(1): 77 - 90. 10.9739/tjvs.2021.807
Vancouver	Aliyev A,Dumantepe M,Şırlak M,Doganci S,POLAT A,aydin u,BEYAZPINAR D,Oğuz E,erdil n,Kaymaz C,Akay H Management of acute pulmonary embolism during COVID-19 pandemic. Turkish journal of vascular surgery. 2021; 30(1): 77 - 90. 10.9739/tjvs.2021.807
IEEE	Aliyev A,Dumantepe M,Şırlak M,Doganci S,POLAT A,aydin u,BEYAZPINAR D,Oğuz E,erdil n,Kaymaz C,Akay H "Management of acute pulmonary embolism during COVID-19 pandemic." Turkish journal of vascular surgery, 30, ss.77 - 90, 2021. 10.9739/tjvs.2021.807
ISNAD	Aliyev, Anar vd. "Management of acute pulmonary embolism during COVID-19 pandemic". Turkish journal of vascular surgery 30/1 (2021), 77-90. https://doi.org/10.9739/tjvs.2021.807